20% of Big 4-audited IPOs report weaknesses in financial-reporting controls
Market Watch published a piece about an SEC proposal to exempt some development-stage biotech and medical device companies from getting an auditor’s opinion on their internal controls. Commissioner Hester Peirce spoke of her support for the proposal at Mendoza's 2019 CARE conference, saying that investors want their money to go to research and growing the company and not to auditors.
- Published
Related News & Stories
In the Classroom
New minors expand access to business education
More business minors are now available to all Notre Dame students—and new minors expand the educational offerings at Mendoza
Analytics & Technology
Reimagining Dementia Care
At the 2026 Shamrock Series, scholars from the Human-centered Analytics Lab demonstrated how in-person facilitators combined with social robots using generative AI can deliver personalized reminiscence therapy for memory care patients.
Mendoza
Meet Notre Dame’s newest business faculty members
Mendoza College of Business welcomes a new cohort of scholars whose research shapes how the College teaches and thinks about today's business challenges.